<SEC-DOCUMENT>0001959173-25-003827-index.html : 20250605
<SEC-HEADER>0001959173-25-003827.hdr.sgml : 20250605
<ACCEPTANCE-DATETIME>20250605112339
ACCESSION NUMBER:		0001959173-25-003827
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250605
DATE AS OF CHANGE:		20250605

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lantheus Holdings, Inc.
		CENTRAL INDEX KEY:			0001521036
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				352318913
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-36569
		FILM NUMBER:		251026172

	BUSINESS ADDRESS:	
		STREET 1:		331 TREBLE COVE ROAD
		CITY:			NORTH BILLERICA
		STATE:			MA
		ZIP:			01862
		BUSINESS PHONE:		978 671-8001

	MAIL ADDRESS:	
		STREET 1:		331 TREBLE COVE ROAD
		CITY:			NORTH BILLERICA
		STATE:			MA
		ZIP:			01862

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Lantheus MI Holdings, Inc.
		DATE OF NAME CHANGE:	20110517

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Blanchfield Paul
		CENTRAL INDEX KEY:			0001801395
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		C/O LANTHEUS HOLDINGS, INC.
		STREET 2:		331
		CITY:			NORTH BILLERICA
		STATE:			MA
		ZIP:			01862
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>